Ways2Capital Reviews : Top Stocks In Focus Today: TCS, NBCC, Panacea Biotech, HCL Infosystems

TCS announced that its Board of Directors, at its meeting held on Friday, has approved a proposal to buy back up to 7,61,90,476 equity shares for an aggregate amount not exceeding Rs16,000cr.

NBCC has submitted a bid in response to Department of Investment and Public Asset Management's invite for strategic disinvestment of HSCC and Engineering Projects (India).

PNC Infratech says lowest bid for Purvanchal Expressway canceled.

Panacea Biotech, along with partner Apotex, settles patent dispute with Celgene Corporation.
Avana Logistek, an associate company of Shreyas Shipping, files DRHP with SEBI for IPO.

HCL Infosystems concludes sale of entire stake in HCL Services to Karvy Data Management Services.
Kanoria Chemicals and Industries to set up Formaldehyde plant with 1 lakh tonne per annum in Andhra Pradesh.
ICICI Bank Board may name Sandeep Bakshi as ICICI Bank Interim CEO
Telecom Department may clear Vodafone-Idea merger today.

Tata Steel: Thyssenkrupp shareholders are said to be skeptical of Tata deal.
Punjab & Sind Bank raises one-year MCLR from 8.5% to 8.6% with effect June 16, 2018.
SMS Lifesciences India has received Establishment Inspection Report from the USFDA for its manufacturing facility, Unit-I, Kazipally (Hyderabad) after its inspection in April.
Filatex India has fixed June 28 as record date for determining shareholders entitled for sub-division of equity shares.
Container Corporation of India has fixed June 27, 2018 as record date for the purpose of sub-division of shares.
Ujjivan Financial Services has received RBI’s approval for appointment of Ittira Davis as MD and CEO of the company effective July 1.
Electrosteel Steels board allotted 1,76,55,06,078 fully paid up equity shares of Rs10 each to Vedanta Star (VSL) on a preferential basis. VSL holds 90% of the paid up share capital of the company.
Fiberweb India said the proposed preferential allotment of equity shares to New Horizon Opportunities Master Fund to the tune of Rs40cr will not be taking place.
KDDL’s board has approved raising funds up to Rs20cr through a preferential issue.
Globalspace Technologies acquires strategic stake of 70.80% in Miljon Medi App.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626191 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717
Share on Google Plus Share on Pinterest

About Bhoomi Desai

0 comments: